Investors and analysts predict the FDA will approve Applied Therapeutics' lead candidate govorestat for classic galactosemia ...
Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.
Zacks.com on MSN5d
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma StudyShares of NuCana plc NCNA skyrocketed 150.8% on Monday after the announcement of encouraging final data from the mid-stage ...
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Nucana (NCNA – Research Report) today. The company’s ...
NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in ...
Instil Bio, Inc. TIL shares dropped 25% to $63.50. The company announced the global registrational strategy for the PD-L1xVEGF bispecific antibody SYN-2510/IMM2510 in combination with chemotherapy in ...
MT Newswires on MSN6d
European Equities Traded in the US as American Depositary Receipts Higher in Monday TradingEuropean equities traded in the US as American depositary receipts started the week higher late Monday morning, rising 0.31% to 1,446.05 on the S&P Europe Select ADR Index. From continental Europe, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback